期刊文献+

虎皮猫用于MZR降压物质的检查 被引量:6

Examining The Depressor Substance in MZR by Tiger Skin Cat
下载PDF
导出
摘要 目的考查虎皮猫用于测定咪唑立宾(MZR)降压物质的效果。方法虎皮猫麻醉后,依次按0.05μg·kg-1、0.10μg·kg-1、0.15μg·kg-1静脉注射磷酸组织胺对照品,测定各剂量磷酸组织胺对猫血压所致的反应值(注射各剂量前后血压的改变幅度),判定猫对磷酸组织胺降压反应的灵敏度。按药典规定方法静脉注射磷酸组织胺和咪唑立宾,观察咪唑立宾在15mg·kg-1、30mg·kg-1、40mg·kg-1剂量下,对猫血压的影响。结果虎皮猫注射不同剂量磷酸组织胺后,血压反应均超过2.67kPa,灵敏度测定合格。每批MZR各剂量dT所致的反应值均不大于ds所致的反应值的一半。结论咪唑立宾降压物质检查符合药典要求,虎皮猫可用于MZR降压物质的检查。 Objective To observe the effective of Tiger skin cat on examination the depressor substance in MZR. Methods The Tiger skin cat were anesthetized and given histamine phosphate at the dose of 0.05 μg·kg^-1, 0.10 μg·kg^-1 and 0.15μg·kg^-1 respectively by intravenous injection. Then the response value of cats' blood pressure at each dose was determined and sensitivity of cats to histamine phosphate was assessed. Histamine phosphate and MZR were injected aeocording to pharmacopeia and the effects of different doses of MZR (0.05 μg·kg^-1,0.10 μg·kg^-1,0.15μg·kg^-1 ) on cats' blood pressure were observed. Results The value of cats' blood pressure exceeded 2.67 kPa after different changes doses of histamine phosphate injection and the sensitivity of cats to histamine phosphate was qualification. The of cats' blood pressure in different MZR were not greater then a half of that induced by histamine phosphate. Conclusions The MZR depressor substance was consistent with pharmacopeia and the Tiger skin cats could be used for the examination of the depressor substance in MZR.
出处 《实验动物科学》 2009年第2期33-35,共3页 Laboratory Animal Science
基金 河北省科技基础条件平台建设项目(编号:077669049D)
关键词 虎皮猫 咪唑立宾 降压物质 Tiger skin cat Mizoribine Depressor substance
  • 相关文献

参考文献4

二级参考文献14

  • 1IHARA H, SHINKUMA D,NOJIMA M, et ol. Clinical Significance of blood level monitoring of mizoribine in kidney transplantation[J]. Transplant Proc, 1994,26(4): 2029-2031.
  • 2SONDA K, TAKAHASHI K, TANABE K, et ol. Clinical pharmacokinetic study of mizoribine in renal transplantation patients[J]. Transplant Proc, 1996,28(6) : 3643-3648.
  • 3KOKADO Y,TAKAHARA S, ISHIBASHI M, et ol. Pharmacokinetics of mizoribine in renal transplant patients[J]. Transplant Proc,1994,26(4) :2111- 2113.
  • 4ERDMANN GA,GRUBER SA, McGUIGGAN MM, et ol. Determination of mizorbine in plasma using ion-pair high performance liquid chromatography[J]. J Chromatogr, 1989,494 ; 354-360.
  • 5TAKADA K,NAKAE H, ASADA S, et al. Rapid method for the high-performance liquid chromatography determination of bredinin in human serum[J]. J Chromatogr, 1981,222 ( 1 ) : 156-159.
  • 6Ishikawa H. Mizoribine and mycophenolate mofetil [ J ]. Curr Med Chem, 1999,6(7) :575 - 597.
  • 7Yokota S. Mizoribine: mode of action and effects in clinical use [ J ].Pediatr Int, 2002,44(2) : 196 - 198.
  • 8Hida H, Mita K, Bekku Y, et al. Advantages of triple therapy with mizoribine, cyclosporine and prednisolone over other types of triple and/or double therapy including cyelosporine for renal transplantation[J]. J Toxicol Sci, 1991,16(4) : 181 - 190.
  • 9Honda M. Nephrotic syndrome and mizoribine in children[J]. Pediatr Ira, 2002,44(2) :210 - 216.
  • 10Takei S. Mizoribine in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis[J]. Pediatr Int, 2002,44(2) : 205 - 209.

共引文献33

同被引文献49

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部